2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialHER2 positive breast carcinoma, invasive breast carcinoma, synchronous bilateral breast carcinomaActive, not recruitingPhase 32026-06-15NCT04457596
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE TrialNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingNot applicable2026-02-18NCT06216574